Tower Research Capital (TRC)’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.1K | Sell |
835
-1,800
| -68% | -$64.9K | ﹤0.01% | 3397 |
|
|
2025
Q1 | $82K | Sell |
2,635
-16,851
| -86% | -$525K | ﹤0.01% | 1885 |
|
|
2024
Q4 | $497K | Sell |
19,486
-309
| -2% | -$7.88K | 0.01% | 1065 |
|
|
2024
Q3 | $560K | Sell |
19,795
-10,053
| -34% | -$284K | 0.01% | 802 |
|
|
2024
Q2 | $787K | Buy |
29,848
+26,646
| +832% | +$703K | 0.01% | 949 |
|
|
2024
Q1 | $97.2K | Sell |
3,202
-14,653
| -82% | -$445K | ﹤0.01% | 1834 |
|
|
2023
Q4 | $502K | Sell |
17,855
-20,588
| -54% | -$578K | 0.01% | 1366 |
|
|
2023
Q3 | $1.04M | Buy |
38,443
+36,857
| +2,324% | +$1M | 0.03% | 524 |
|
|
2023
Q2 | $48.8K | Sell |
1,586
-387
| -20% | -$11.9K | ﹤0.01% | 2584 |
|
|
2023
Q1 | $71K | Sell |
1,973
-11,842
| -86% | -$426K | ﹤0.01% | 2190 |
|
|
2022
Q4 | $546K | Buy |
13,815
+11,035
| +397% | +$436K | 0.02% | 653 |
|
|
2022
Q3 | $112K | Sell |
2,780
-3,465
| -55% | -$140K | ﹤0.01% | 2467 |
|
|
2022
Q2 | $263K | Buy |
6,245
+356
| +6% | +$15K | 0.01% | 1580 |
|
|
2022
Q1 | $229K | Sell |
5,889
-10,109
| -63% | -$393K | ﹤0.01% | 1635 |
|
|
2021
Q4 | $638K | Buy |
15,998
+14,438
| +926% | +$576K | 0.01% | 951 |
|
|
2021
Q3 | $57K | Sell |
1,560
-27,047
| -95% | -$988K | ﹤0.01% | 2844 |
|
|
2021
Q2 | $1.17M | Buy |
28,607
+24,136
| +540% | +$989K | 0.03% | 549 |
|
|
2021
Q1 | $195K | Buy |
4,471
+2,414
| +117% | +$105K | ﹤0.01% | 2033 |
|
|
2020
Q4 | $103K | Buy |
2,057
+1,558
| +312% | +$78K | ﹤0.01% | 2318 |
|
|
2020
Q3 | $21K | Buy |
+499
| New | +$21K | ﹤0.01% | 3852 |
|